Nicholas K. Akers
Nicholas K. Akers
Unknown affiliation
Verified email at
Cited by
Cited by
Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features
D Sia, Y Jiao, I Martinez-Quetglas, O Kuchuk, C Villacorta-Martin, ...
Gastroenterology 153 (3), 812-826, 2017
Cardiometabolic risk loci share downstream cis-and trans-gene regulation across tissues and diseases
O Franzén, R Ermel, A Cohain, NK Akers, A Di Narzo, HA Talukdar, ...
Science 353 (6301), 827-830, 2016
Intratumoral heterogeneity and clonal evolution in liver cancer
B Losic, AJ Craig, C Villacorta-Martin, SN Martins-Filho, N Akers, X Chen, ...
Nature communications 11 (1), 291, 2020
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21. 32
L Conde, E Halperin, NK Akers, KM Brown, KE Smedby, N Rothman, ...
Nature genetics 42 (8), 661-664, 2010
Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region
CF Skibola, SI Berndt, J Vijai, L Conde, Z Wang, M Yeager, ...
The American Journal of Human Genetics 95 (4), 462-471, 2014
Phase 2 trial of gemcitabine, cisplatin, plus ipilimumab in patients with metastatic urothelial cancer and impact of DNA damage response gene mutations on outcomes
MD Galsky, H Wang, NM Hahn, P Twardowski, SK Pal, C Albany, ...
European urology 73 (5), 751-759, 2018
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple …
T Ching, ME Duncan, T Newman-Eerkes, MME McWhorter, JM Tracy, ...
BMC cancer 20 (1), 1-15, 2020
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
J Carrillo-Reixach, L Torrens, M Simon-Coma, L Royo, M Domingo-Sàbat, ...
Journal of hepatology 73 (2), 328-341, 2020
Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N‐6 adenine‐specific DNA methyltransferase 1 (N6AMT1) polymorphisms …
R De la Rosa, C Steinmaus, NK Akers, L Conde, C Ferreccio, D Kalman, ...
Environmental and molecular mutagenesis 58 (6), 411-422, 2017
Multi‐locus HLA class I and II allele and haplotype associations with follicular lymphoma
CF Skibola, NK Akers, L Conde, M Ladner, SK Hawbecker, F Cohen, ...
Tissue antigens 79 (4), 279-286, 2012
STAR Chimeric Post for rapid detection of circular RNA and fusion transcripts
NK Akers, EE Schadt, B Losic
Bioinformatics 34 (14), 2364-2370, 2018
Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk
JN Foo, KE Smedby, NK Akers, M Berglund, ID Irwan, X Jia, Y Li, L Conde, ...
The American Journal of Human Genetics 93 (1), 167-172, 2013
Common variants within 6p21. 31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non‐H odgkin lymphoma subtypes
SL Slager, NJ Camp, L Conde, TD Shanafelt, SJ Achenbach, KG Rabe, ...
British journal of haematology 159 (5), 572-576, 2012
Association of HLA-DQB1 alleles with risk of follicular lymphoma
NK Akers, JD Curry, L Conde, PM Bracci, MT Smith, CF Skibola
Leukemia & lymphoma 52 (1), 53-58, 2011
Follicular lymphoma-protective HLA class II variants correlate with increased HLA-DQB1 protein expression
FCM Sillé, L Conde, J Zhang, NK Akers, S Sanchez, J Maltbaek, JE Riby, ...
Genes & Immunity 15 (2), 133-136, 2014
Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits
BS Glicksberg, L Amadori, NK Akers, K Sukhavasi, O Franzén, L Li, ...
BMC Medical Genomics 12, 1-16, 2019
Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors
A Bubie, E Gonzalez-Kozlova, N Akers, A Villanueva, B Losic
Scientific Reports 10 (1), 5062, 2020
DNA damage response (DDR) gene mutations (mut), mut load, and sensitivity to chemotherapy plus immune checkpoint blockade in urothelial cancer (UC).
MD Galsky, AV Uzilov, RB McBride, H Wang, VG Patel, J Sfakianos, ...
Journal of Clinical Oncology 35 (6_suppl), 300-300, 2017
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
J Abril-Fornaguera, L Torrens, C Andreu-Oller, J Carrillo-Reixach, ...
Molecular Cancer Therapeutics 22 (4), 485-498, 2023
Multiplexed, ligation‐dependent probe amplification for rapid and inexpensive HLA‐DQB1 allelotyping
NK Akers, JD Curry, MT Smith, PM Bracci, CF Skibola
Tissue antigens 78 (4), 275-280, 2011
The system can't perform the operation now. Try again later.
Articles 1–20